Patents by Inventor Robert Guttendorf

Robert Guttendorf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions and methods for improved bacterial eradication
    Patent number: 8299052
    Abstract: A process for treating a bacterial infection with an antibiotic, comprising: administering to a patient with a bacterial infection a product that includes a modified release dosage form containing an antibiotic, said product being administered once-a-day in a dosage and for a number of days that provides a Total T>MIC sufficient to achieve at least the minimum amount of bacterial eradication for treatment of said bacterial infection.
    Type: Grant
    Filed: May 7, 2007
    Date of Patent: October 30, 2012
    Assignee: Shionogi Inc.
    Inventors: Henry H. Flanner, Robert Guttendorf, Donald Treacy, Susan P. Clausen, Beth A. Burnside
  • Pharmaceutical compositions and methods for improved bacterial eradication
    Publication number: 20080050430
    Abstract: A process for treating a bacterial infection with an antibiotic, comprising: administering to a patient with a bacterial infection a product that includes a modified release dosage form containing an antibiotic, said product being administered once-a-day in a dosage and for a number of days that provides a Total T>MIC sufficient to achieve at least the minimum amount of bacterial eradication for treatment of said bacterial infection.
    Type: Application
    Filed: May 7, 2007
    Publication date: February 28, 2008
    Inventors: Henry Flanner, Robert Guttendorf, Donald Treacy, Susan Clausen, Beth Burnside
  • Compositions and methods for improved efficacy of penicillin-type antibiotics
    Publication number: 20070134327
    Abstract: Disclosed are once-a-day penicillin-type antibiotic products comprising at least one modified release dosage form comprising penicillin-type antibiotics and pharmaceutically acceptable carriers, which compositions provide T>MIC90 in the serum for at least 5 hours (preferably for at least five consecutive hours), within a 24-hour dosing interval, for a given bacterial pathogen's MIC90, while providing a total dosage of the penicillin-type antibiotic for a 24-hour dosing interval.
    Type: Application
    Filed: December 8, 2006
    Publication date: June 14, 2007
    Inventors: Henry Flanner, Robert Guttendorf, Susan Clausen, Donald Treacy, Beth Burnside
  • Enhanced absorption of modified release dosage forms
    Publication number: 20050142187
    Abstract: Disclosed are products and methods for improving the plasma profile in a patient being treated with a pharmaceutical active agent that is subject to a limited window of absorption, which products and methods comprise orally administering the active agent in multiparticulate form, such that at least a portion thereof is delivered to the intestine while the patient is in the fed condition.
    Type: Application
    Filed: December 23, 2004
    Publication date: June 30, 2005
    Inventors: Donald Treacy, Henry Flanner, Robert Guttendorf, Beth Burnside